{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:03:53Z","timestamp":1778407433339,"version":"3.51.4"},"publisher-location":"Cham","reference-count":186,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030284701","type":"print"},{"value":"9783030284718","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-3-030-28471-8_1","type":"book-chapter","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T17:12:21Z","timestamp":1572023541000},"page":"1-31","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pluripotent Stem Cells to Model Degenerative Retinal Diseases: The RPE Perspective"],"prefix":"10.1007","author":[{"given":"Sonal","family":"Dalvi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chad A.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruchira","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,26]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1124\/mi.10.5.4","volume":"10","author":"Y Chen","year":"2010","unstructured":"Chen Y, Bedell M, Zhang K (2010) Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv 10:271\u2013281","journal-title":"Mol Interv"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"16016","DOI":"10.1038\/sigtrans.2016.16","volume":"1","author":"W Wang","year":"2016","unstructured":"Wang W, Gawlik K, Lopez J et al (2016) Genetic and environmental factors strongly influence risk, severity and progression of age-related macular degeneration. Signal Transduct Target Ther 1:16016","journal-title":"Signal Transduct Target Ther"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/138920211795860107","volume":"12","author":"S Ferrari","year":"2011","unstructured":"Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F (2011) Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 12:238\u2013249","journal-title":"Curr Genomics"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/bjophthalmol-2016-308823","volume":"101","author":"P Tanna","year":"2017","unstructured":"Tanna P, Strauss RW, Fujinami K, Michaelides M (2017) Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol 101:25\u201330","journal-title":"Br J Ophthalmol"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/hmg\/11.10.1169","volume":"11","author":"FPM Cremers","year":"2002","unstructured":"Cremers FPM, van den Hurk JAJM, den Hollander AI (2002) Molecular genetics of Leber congenital amaurosis. Hum Mol Genet 11:1169\u20131176","journal-title":"Hum Mol Genet"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","volume":"28","author":"CJ Boon","year":"2009","unstructured":"Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, den Hollander AI (2009) The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res 28:187\u2013205","journal-title":"Prog Retin Eye Res"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1152\/physrev.00022.2007","volume":"88","author":"HC Hartzell","year":"2008","unstructured":"Hartzell HC, Qu Z, Yu K, Xiao Q, Chien LT (2008) Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev 88:639\u2013672","journal-title":"Physiol Rev"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1001\/archopht.123.11.1484","volume":"123","author":"MD Davis","year":"2005","unstructured":"Davis MD, Gangnon RE, Lee LY et al (2005) The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol 123:1484\u20131498","journal-title":"Arch Ophthalmol"},{"key":"1_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.mam.2012.04.005","volume":"33","author":"I Bhutto","year":"2012","unstructured":"Bhutto I, Lutty G (2012) Understanding age-related macular degeneration (AMD): relationships between the photoreceptor\/retinal pigment epithelium\/Bruch\u2019s membrane\/choriocapillaris complex. Mol Asp Med 33:295\u2013317","journal-title":"Mol Asp Med"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1136\/bjo.82.11.1329","volume":"82","author":"RN Fariss","year":"1998","unstructured":"Fariss RN, Apte SS, Luthert PJ, Bird AC, Milam AH (1998) Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby\u2019s fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol 82:1329\u20131334","journal-title":"Br J Ophthalmol"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archopht.1982.01030040086016","volume":"100","author":"TA Weingeist","year":"1982","unstructured":"Weingeist TA, Kobrin JL, Watzke RC (1982) Histopathology of Best\u2019s macular dystrophy. Arch Ophthalmol 100:1108\u20131114","journal-title":"Arch Ophthalmol"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1152\/physrev.00021.2004","volume":"85","author":"O Strauss","year":"2005","unstructured":"Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845\u2013881","journal-title":"Physiol Rev"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/156652410793937813","volume":"10","author":"JR Sparrow","year":"2010","unstructured":"Sparrow JR, Hicks D, Hamel CP (2010) The retinal pigment epithelium in health and disease. Curr Mol Med 10:802\u2013823","journal-title":"Curr Mol Med"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1167\/iovs.08-1700","volume":"49","author":"B R\u00f3\u017canowski","year":"2008","unstructured":"R\u00f3\u017canowski B, Burke JM, Boulton ME, Sarna T, R\u00f3\u017canowska M (2008) Human RPE melanosomes protect from photosensitized and iron-mediated oxidation but become pro-oxidant in the presence of iron upon photodegradation. Invest Ophthalmol Vis Sci 49:2838\u20132847","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S1471-4914(02)02362-6","volume":"8","author":"N Bouck","year":"2002","unstructured":"Bouck N (2002) PEDF: anti-angiogenic guardian of ocular function. Trends Mol Med 8:330\u2013334","journal-title":"Trends Mol Med"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1093\/hmg\/ddi385","volume":"14","author":"KP Langton","year":"2005","unstructured":"Langton KP, McKie N, Smith BM, Brown NJ, Barker MD (2005) Sorsby\u2019s fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. Hum Mol Genet 14:3579\u20133586","journal-title":"Hum Mol Genet"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"30469","DOI":"10.1074\/jbc.M403026200","volume":"279","author":"PA Klenotic","year":"2004","unstructured":"Klenotic PA, Munier FL, Marmorstein LY, Anand-Apte B (2004) Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) - implications for macular degenerations. J Biol Chem 279:30469\u201330473","journal-title":"J Biol Chem"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/hmg\/9.4.645","volume":"9","author":"PM D\u2019Cruz","year":"2000","unstructured":"D\u2019Cruz PM, Yasumura D, Weir J et al (2000) Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 9:645\u2013651","journal-title":"Hum Mol Genet"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1167\/iovs.02-0438","volume":"44","author":"JL Duncan","year":"2003","unstructured":"Duncan JL, LaVail MM, Yasumura D et al (2003) An RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol Vis Sci 44:826\u2013838","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"12910","DOI":"10.1038\/srep12910","volume":"5","author":"D Lukovic","year":"2015","unstructured":"Lukovic D, Artero Castro A, Delgado ABG et al (2015) Human iPSC derived disease model of MERTK-associated retinitis pigmentosa. Sci Rep 5:12910","journal-title":"Sci Rep"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41598-017-00142-7","volume":"7","author":"CM Ramsden","year":"2017","unstructured":"Ramsden CM, Nommiste B, R Lane A et al (2017) Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs. Sci Rep 7:51","journal-title":"Sci Rep"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"E8214","DOI":"10.1073\/pnas.1710430114","volume":"114","author":"CA Galloway","year":"2017","unstructured":"Galloway CA, Dalvi S, Hung SSC et al (2017) Drusen in patient-derived hiPSC-RPE models of macular dystrophies. Proc Natl Acad Sci U S A 114:E8214\u2013E8223","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/hmg\/ddx392","volume":"27","author":"R Fernandez-Godino","year":"2018","unstructured":"Fernandez-Godino R, Bujakowska KM, Pierce EA (2018) Changes in extracellular matrix cause RPE cells to make basal deposits and activate the alternative complement pathway. Hum Mol Genet 27:147\u2013159","journal-title":"Hum Mol Genet"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106\u2013e116","journal-title":"Lancet Glob Health"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1001\/archophthalmol.2010.318","volume":"129","author":"R Klein","year":"2011","unstructured":"Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB (2011) Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 129:75\u201380","journal-title":"Arch Ophthalmol"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2012.10.018","volume":"155","author":"JW Miller","year":"2013","unstructured":"Miller JW (2013) Age-related macular degeneration revisited\u2014piecing the puzzle: the LXIX Edward Jackson Memorial Lecture. Am J Ophthalmol 155:1\u201335.e13","journal-title":"Am J Ophthalmol"},{"key":"1_CR27","first-page":"465","volume-title":"Retina","author":"C Curcio","year":"2012","unstructured":"Curcio C, Johnson M (2012) Structure, function, and pathology of Bruch\u2019s membrane. In: Retina, vol 1, 5th edn. Elsevier, Amsterdam, pp 465\u2013481","edition":"5"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1097\/IAE.0b013e3181ee5ce8","volume":"30","author":"RF Spaide","year":"2010","unstructured":"Spaide RF, Curcio CA (2010) Drusen characterization with multimodal imaging. Retina 30:1441\u20131454","journal-title":"Retina"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ophtha.2006.10.040","volume":"114","author":"R Klein","year":"2007","unstructured":"Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE (2007) Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology 114:253\u2013262","journal-title":"Ophthalmology"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki M, Raisler BJ, Sakurai E et al (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103:2328\u20132333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR31","doi-asserted-by":"publisher","first-page":"11282","DOI":"10.1073\/pnas.0602131103","volume":"103","author":"Y Imamura","year":"2006","unstructured":"Imamura Y, Noda S, Hashizume K et al (2006) Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A 103:11282\u201311287","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/gim.2015.70","volume":"18","author":"JR Black","year":"2016","unstructured":"Black JR, Clark SJ (2016) Age-related macular degeneration: genome-wide association studies to translation. Genet Med 18:283\u2013289","journal-title":"Genet Med"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ajo.2010.08.015","volume":"151","author":"L Sobrin","year":"2011","unstructured":"Sobrin L, Reynolds R, Yu Y et al (2011) ARMS2\/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol 151:345\u2013352.e343","journal-title":"Am J Ophthalmol"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng1294-352","volume":"8","author":"BH Weber","year":"1994","unstructured":"Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U (1994) Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby\u2019s fundus dystrophy. Nat Genet 8:352\u2013356","journal-title":"Nat Genet"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/9722","volume":"22","author":"EM Stone","year":"1999","unstructured":"Stone EM, Lotery AJ, Munier FL et al (1999) A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet 22:199\u2013202","journal-title":"Nat Genet"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/hmg\/ddg289","volume":"12","author":"C Hayward","year":"2003","unstructured":"Hayward C, Shu X, Cideciyan AV et al (2003) Mutation in a short-chain collagen gene, CTRP5, results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Hum Mol Genet 12:2657\u20132667","journal-title":"Hum Mol Genet"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.1167\/iovs.05-0159","volume":"46","author":"R Ayyagari","year":"2005","unstructured":"Ayyagari R, Mandal MNA, Karoukis AJ et al (2005) Late-onset macular degeneration and long anterior lens zonules result from a CTRP5 gene mutation. Invest Ophthalmol Vis Sci 46:3363\u20133371","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/bjo.33.2.67","volume":"33","author":"A Sorsby","year":"1949","unstructured":"Sorsby A, Mason ME (1949) A fundus dystrophy with unusual features. Br J Ophthalmol 33:67\u201397","journal-title":"Br J Ophthalmol"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/bjo.65.12.859","volume":"65","author":"A Hoskin","year":"1981","unstructured":"Hoskin A, Sehmi K, Bird AC (1981) Sorsby\u2019s pseudoinflammatory macular dystrophy. Br J Ophthalmol 65:859\u2013865","journal-title":"Br J Ophthalmol"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.exer.2017.08.014","volume":"165","author":"DRG Christensen","year":"2017","unstructured":"Christensen DRG, Brown FE, Cree AJ, Ratnayaka JA, Lotery AJ (2017) Sorsby fundus dystrophy\u2014a review of pathology and disease mechanisms. Exp Eye Res 165:35\u201346","journal-title":"Exp Eye Res"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"16778","DOI":"10.1074\/jbc.273.27.16778","volume":"273","author":"KP Langton","year":"1998","unstructured":"Langton KP, Barker MD, McKie N (1998) Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby\u2019s fundus dystrophy mutation. J Biol Chem 273:16778\u201316781","journal-title":"J Biol Chem"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb JW, Miyagi M, Gu X et al (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99:14682","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN et al (2016) A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet 48:134\u2013143","journal-title":"Nat Genet"},{"key":"1_CR44","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1093\/hmg\/ddm199","volume":"16","author":"LY Marmorstein","year":"2007","unstructured":"Marmorstein LY, McLaughlin PJ, Peachey NS, Sasaki T, Marmorstein AD (2007) Formation and progression of sub-retinal pigment epithelium deposits in Efemp1 mutation knock-in mice: a model for the early pathogenic course of macular degeneration. Hum Mol Genet 16:2423\u20132432","journal-title":"Hum Mol Genet"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"13067","DOI":"10.1073\/pnas.202491599","volume":"99","author":"LY Marmorstein","year":"2002","unstructured":"Marmorstein LY, Munier FL, Arsenijevic Y et al (2002) Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc Natl Acad Sci U S A 99:13067\u201313072","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1167\/iovs.05-0070","volume":"46","author":"CN Roybal","year":"2005","unstructured":"Roybal CN, Marmorstein LY, Vander Jagt DL, Abcouwer SF (2005) Aberrant accumulation of fibulin-3 in the endoplasmic reticulum leads to activation of the unfolded protein response and VEGF expression. Invest Ophthalmol Vis Sci 46:3973\u20133979","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","volume":"16","author":"L Fu","year":"2007","unstructured":"Fu L, Garland D, Yang Z et al (2007) The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16:2411\u20132422","journal-title":"Hum Mol Genet"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1093\/hmg\/ddm264","volume":"16","author":"PJ McLaughlin","year":"2007","unstructured":"McLaughlin PJ, Bakall B, Choi J et al (2007) Lack of fibulin-3 causes early aging and herniation, but not macular degeneration in mice. Hum Mol Genet 16:3059\u20133070","journal-title":"Hum Mol Genet"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","volume":"24","author":"R Fernandez-Godino","year":"2015","unstructured":"Fernandez-Godino R, Garland DL, Pierce EA (2015) A local complement response by RPE causes early-stage macular degeneration. Hum Mol Genet 24:5555\u20135569","journal-title":"Hum Mol Genet"},{"key":"1_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027433","volume":"6","author":"X Shu","year":"2011","unstructured":"Shu X, Luhmann UFO, Aleman TS et al (2011) Characterisation of a C1qtnf5 Ser163Arg knock-in mouse model of late-onset retinal macular degeneration. PLoS One 6:e27433","journal-title":"PLoS One"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1093\/hmg\/ddl091","volume":"15","author":"X Shu","year":"2006","unstructured":"Shu X, Tulloch B, Lennon A et al (2006) Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5. Hum Mol Genet 15:1680\u20131689","journal-title":"Hum Mol Genet"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/jamaophthalmol.2014.2059","volume":"132","author":"SG Jacobson","year":"2014","unstructured":"Jacobson SG, Cideciyan AV, Sumaroka A, Roman AJ, Wright AF (2014) Late-onset retinal degeneration caused by C1QTNF5 mutation: sub-retinal pigment epithelium deposits and visual consequences. JAMA Ophthalmol 132:1252\u20131255","journal-title":"JAMA Ophthalmol"},{"key":"1_CR53","first-page":"284","volume":"93","author":"S Borooah","year":"2009","unstructured":"Borooah S, Collins C, Wright A, Dhillon B (2009) Late-onset retinal macular degeneration: clinical insights into an inherited retinal degeneration. Br J Ophthalmol 93:284","journal-title":"Br J Ophthalmol"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/archopht.118.1.85","volume":"118","author":"R Ayyagari","year":"2000","unstructured":"Ayyagari R, Griesinger IB, Bingham E, Lark KK, Moroi SE, Sieving PA (2000) Autosomal dominant hemorrhagic macular dystrophy not associated with the TIMP3 gene. Arch Ophthalmol 118:85\u201392","journal-title":"Arch Ophthalmol"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.ajo.2005.06.023","volume":"140","author":"V Subrayan","year":"2005","unstructured":"Subrayan V, Morris B, Armbrecht AM, Wright AF, Dhillon B (2005) Long anterior lens zonules in late-onset retinal degeneration (L-ORD). Am J Ophthalmol 140:1127\u20131129","journal-title":"Am J Ophthalmol"},{"key":"1_CR56","first-page":"1772","volume":"37","author":"CA Kuntz","year":"1996","unstructured":"Kuntz CA, Jacobson SG, Cideciyan AV et al (1996) Sub-retinal pigment epithelial deposits in a dominant late-onset retinal degeneration. Invest Ophthalmol Vis Sci 37:1772\u20131782","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0002-9394(98)00097-X","volume":"126","author":"AO Edwards","year":"1998","unstructured":"Edwards AO, Klein ML, Berselli CB et al (1998) Malattia leventinese: refinement of the genetic locus and phenotypic variability in autosomal dominant macular drusen. Am J Ophthalmol 126:417\u2013424","journal-title":"Am J Ophthalmol"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archopht.1997.01100160074012","volume":"115","author":"K Evans","year":"1997","unstructured":"Evans K, Gregory CY, Wijesuriya SD et al (1997) Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy. Arch Ophthalmol 115:904\u2013910","journal-title":"Arch Ophthalmol"},{"key":"1_CR59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00424-010-0821-5","volume":"460","author":"Q Xiao","year":"2010","unstructured":"Xiao Q, Hartzell HC, Yu K (2010) Bestrophins and retinopathies. Pflugers Archiv 460:559\u2013569","journal-title":"Pflugers Archiv"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1093\/hmg\/7.9.1517","volume":"7","author":"A Marquardt","year":"1998","unstructured":"Marquardt A, Stohr H, Passmore LA, Kramer F, Rivera A, Weber BH (1998) Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best\u2019s disease). Hum Mol Genet 7:1517\u20131525","journal-title":"Hum Mol Genet"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.ejhg.5200447","volume":"8","author":"F Kramer","year":"2000","unstructured":"Kramer F, White K, Pauleikhoff D et al (2000) Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet 8:286\u2013292","journal-title":"Eur J Hum Genet"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajhg.2007.08.004","volume":"82","author":"R Burgess","year":"2008","unstructured":"Burgess R, Millar ID, Leroy BP et al (2008) Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 82:19\u201331","journal-title":"Am J Hum Genet"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1167\/iovs.04-0550","volume":"45","author":"J Yardley","year":"2004","unstructured":"Yardley J, Leroy BP, Hart-Holden N et al (2004) Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci 45:3683\u20133689","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ajhg.2009.09.015","volume":"85","author":"AE Davidson","year":"2009","unstructured":"Davidson AE, Millar ID, Urquhart JE et al (2009) Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet 85:581\u2013592","journal-title":"Am J Hum Genet"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"e29914","DOI":"10.7554\/eLife.29914","volume":"6","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang Y, Xu Y et al (2017) Patient-specific mutations impair BESTROPHIN1\u2019s essential role in mediating Ca(2+)-dependent Cl(\u2212) currents in human RPE. elife 6:e29914","journal-title":"elife"},{"key":"1_CR66","first-page":"2672","volume":"25","author":"Y Moshfegh","year":"2016","unstructured":"Moshfegh Y, Velez G, Li Y, Bassuk AG, Mahajan VB, Tsang SH (2016) BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE. Hum Mol Genet 25:2672\u20132680","journal-title":"Hum Mol Genet"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1093\/hmg\/ddp583","volume":"19","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Stanton JB, Wu J et al (2010) Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet 19:1108\u20131118","journal-title":"Hum Mol Genet"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1038\/s41598-018-21651-z","volume":"8","author":"AD Marmorstein","year":"2018","unstructured":"Marmorstein AD, Johnson AA, Bachman LA et al (2018) Mutant Best1 expression and impaired phagocytosis in an iPSC model of autosomal recessive Bestrophinopathy. Sci Rep 8:4487","journal-title":"Sci Rep"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/hmg\/dds469","volume":"22","author":"R Singh","year":"2013","unstructured":"Singh R, Shen W, Kuai D et al (2013) iPS cell modeling of Best disease: insights into the pathophysiology of an inherited macular degeneration. Hum Mol Genet 22:593\u2013607","journal-title":"Hum Mol Genet"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.exer.2007.02.018","volume":"85","author":"B Bakall","year":"2007","unstructured":"Bakall B, Radu RA, Stanton JB et al (2007) Enhanced accumulation of A2E in individuals homozygous or heterozygous for mutations in BEST1 (VMD2). Exp Eye Res 85:34\u201343","journal-title":"Exp Eye Res"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1601-5223.1977.tb01394.x","volume":"84","author":"S Nordstrom","year":"1977","unstructured":"Nordstrom S, Barkman Y (1977) Hereditary maculardegeneration (HMD) in 246 cases traced to one gene-source in Central Sweden. Hereditas 84:163\u2013176","journal-title":"Hereditas"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-319-17121-0_38","volume":"854","author":"JR Sparrow","year":"2016","unstructured":"Sparrow JR, Duncker T, Woods R, Delori FC (2016) Quantitative fundus autofluorescence in Best vitelliform macular dystrophy: RPE lipofuscin is not increased in non-lesion areas of retina. Adv Exp Med Biol 854:285\u2013290","journal-title":"Adv Exp Med Biol"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/hmg\/11.10.1219","volume":"11","author":"C Rivolta","year":"2002","unstructured":"Rivolta C, Sharon D, DeAngelis MM, Dryja TP (2002) Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum Mol Genet 11:1219\u20131227","journal-title":"Hum Mol Genet"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-1-40","volume":"1","author":"C Hamel","year":"2006","unstructured":"Hamel C (2006) Retinitis pigmentosa. Orphanet J Rare Dis 1:40","journal-title":"Orphanet J Rare Dis"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/cge.12203","volume":"84","author":"SP Daiger","year":"2013","unstructured":"Daiger SP, Sullivan LS, Bowne SJ (2013) Genes and mutations causing retinitis pigmentosa. Clin Genet 84:132\u2013141","journal-title":"Clin Genet"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"bau047","DOI":"10.1093\/database\/bau047","volume":"2014","author":"X Ran","year":"2014","unstructured":"Ran X, Cai W-J, Huang X-F et al (2014) \u2018RetinoGenetics\u2019: a comprehensive mutation database for genes related to inherited retinal degeneration. Database 2014:bau047","journal-title":"Database"},{"key":"1_CR77","first-page":"1483","volume":"12","author":"R Ayala-Ramirez","year":"2006","unstructured":"Ayala-Ramirez R, Graue-Wiechers F, Robredo V, Amato-Almanza M, Horta-Diez I, Zenteno JC (2006) A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation. Mol Vis 12:1483\u20131489","journal-title":"Mol Vis"},{"key":"1_CR78","first-page":"540","volume":"16","author":"R Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay R, Sergouniotis PI, Mackay DS et al (2010) A detailed phenotypic assessment of individuals affected by MFRP-related oculopathy. Mol Vis 16:540\u2013548","journal-title":"Mol Vis"},{"key":"1_CR79","first-page":"1485","volume":"17","author":"E Ostergaard","year":"2011","unstructured":"Ostergaard E, Duno M, Batbayli M, Vilhelmsen K, Rosenberg T (2011) A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases. Mol Vis 17:1485\u20131492","journal-title":"Mol Vis"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ng1097-198","volume":"17","author":"MA Maw","year":"1997","unstructured":"Maw MA, Kennedy B, Knight A et al (1997) Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa. Nat Genet 17:198\u2013200","journal-title":"Nat Genet"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1038\/mt.2014.100","volume":"22","author":"Y Li","year":"2014","unstructured":"Li Y, Wu WH, Hsu CW et al (2014) Gene therapy in patient-specific stem cell lines and a preclinical model of retinitis pigmentosa with membrane frizzled-related protein defects. Mol Ther 22:1688\u20131697","journal-title":"Mol Ther"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1074\/jbc.274.13.8577","volume":"274","author":"H Stecher","year":"1999","unstructured":"Stecher H, Gelb MH, Saari JC, Palczewski K (1999) Preferential release of 11-cis-retinol from retinal pigment epithelial cells in the presence of cellular retinaldehyde-binding protein. J Biol Chem 274:8577\u20138585","journal-title":"J Biol Chem"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0896-6273(01)00248-3","volume":"29","author":"JC Saari","year":"2001","unstructured":"Saari JC, Nawrot M, Kennedy BN et al (2001) Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron 29:739\u2013748","journal-title":"Neuron"},{"key":"1_CR84","first-page":"588","volume":"13","author":"MO Sweeney","year":"2007","unstructured":"Sweeney MO, McGee TL, Berson EL, Dryja TP (2007) Low prevalence of LRAT mutations in patients with Leber congenital amaurosis and autosomal recessive retinitis pigmentosa. Mol Vis 13:588\u2013593","journal-title":"Mol Vis"},{"key":"1_CR85","first-page":"4293","volume":"41","author":"DA Thompson","year":"2000","unstructured":"Thompson DA, Gy\u00fcr\u00fcs P, Fleischer LL et al (2000) Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci 41:4293\u20134299","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1001\/archopht.119.11.1643","volume":"119","author":"S Dithmar","year":"2001","unstructured":"Dithmar S, Sharara NA, Curcio CA et al (2001) Murine high-fat diet and laser photochemical model of basal deposits in Bruch membrane. Arch Ophthalmol 119:1643\u20131649","journal-title":"Arch Ophthalmol"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1076\/0271-3683(200001)2011-HFT008","volume":"20","author":"MV Miceli","year":"2000","unstructured":"Miceli MV, Newsome DA, Tate DJ Jr, Sarphie TG (2000) Pathologic changes in the retinal pigment epithelium and Bruch\u2019s membrane of fat-fed atherogenic mice. Curr Eye Res 20:8\u201316","journal-title":"Curr Eye Res"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1136\/bjo.2005.071183","volume":"89","author":"M Rudolf","year":"2005","unstructured":"Rudolf M, Winkler B, Aherrahou Z, Doehring LC, Kaczmarek P, Schmidt-Erfurth U (2005) Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch\u2019s membrane of LDL receptor knockout mice. Br J Ophthalmol 89:1627\u20131630","journal-title":"Br J Ophthalmol"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1097\/00006982-200308000-00012","volume":"23","author":"JR Heckenlively","year":"2003","unstructured":"Heckenlively JR, Hawes NL, Friedlander M et al (2003) Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23:518\u2013522","journal-title":"Retina"},{"key":"1_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004160","volume":"4","author":"AL Wang","year":"2009","unstructured":"Wang AL, Lukas TJ, Yuan M, Du N, Tso MO, Neufeld AH (2009) Autophagy and exosomes in the aged retinal pigment epithelium: possible relevance to drusen formation and age-related macular degeneration. PLoS One 4:e4160","journal-title":"PLoS One"},{"key":"1_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003119","volume":"3","author":"M Fujihara","year":"2008","unstructured":"Fujihara M, Nagai N, Sussan TE, Biswal S, Handa JT (2008) Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS One 3:e3119","journal-title":"PLoS One"},{"key":"1_CR92","first-page":"1588","volume":"17","author":"C Luo","year":"2011","unstructured":"Luo C, Chen M, Xu H (2011) Complement gene expression and regulation in mouse retina and retinal pigment epithelium\/choroid. Mol Vis 17:1588\u20131597","journal-title":"Mol Vis"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.exer.2013.04.016","volume":"112","author":"C Luo","year":"2013","unstructured":"Luo C, Zhao J, Madden A, Chen M, Xu H (2013) Complement expression in retinal pigment epithelial cells is modulated by activated macrophages. Exp Eye Res 112:93\u2013101","journal-title":"Exp Eye Res"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ, Zeiss C, Chew EY et al (2005) Complement factor H polymorphism in age-related macular degeneration. Science 308:385\u2013389","journal-title":"Science"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"16651","DOI":"10.1073\/pnas.0705079104","volume":"104","author":"PJ Coffey","year":"2007","unstructured":"Coffey PJ, Gias C, McDermott CJ et al (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104:16651\u201316656","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"5878","DOI":"10.1167\/iovs.09-4457","volume":"51","author":"RL Ufret-Vincenty","year":"2010","unstructured":"Ufret-Vincenty RL, Aredo B, Liu X et al (2010) Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. Invest Ophthalmol Vis Sci 51:5878\u20135887","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/nm950","volume":"9","author":"J Ambati","year":"2003","unstructured":"Ambati J, Anand A, Fernandez S et al (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9:1390\u20131397","journal-title":"Nat Med"},{"key":"1_CR98","first-page":"1253","volume":"20","author":"P Alexander","year":"2014","unstructured":"Alexander P, Gibson J, Cree AJ, Ennis S, Lotery AJ (2014) Complement factor I and age-related macular degeneration. Mol Vis 20:1253\u20131257","journal-title":"Mol Vis"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng1750","volume":"38","author":"B Gold","year":"2006","unstructured":"Gold B, Merriam JE, Zernant J et al (2006) Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38:458\u2013462","journal-title":"Nat Genet"},{"key":"1_CR100","first-page":"2732","volume":"43","author":"BH Weber","year":"2002","unstructured":"Weber BH, Lin B, White K et al (2002) A mouse model for Sorsby fundus dystrophy. Invest Ophthalmol Vis Sci 43:2732\u20132740","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1093\/hmg\/ddr080","volume":"20","author":"VRM Chavali","year":"2011","unstructured":"Chavali VRM, Khan NW, Cukras CA, Bartsch D-U, Jablonski MM, Ayyagari R (2011) A CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration. Hum Mol Genet 20:2000\u20132014","journal-title":"Hum Mol Genet"},{"key":"1_CR102","first-page":"273","volume":"21","author":"B Sahu","year":"2015","unstructured":"Sahu B, Chavali VR, Alapati A et al (2015) Presence of rd8 mutation does not alter the ocular phenotype of late-onset retinal degeneration mouse model. Mol Vis 21:273\u2013284","journal-title":"Mol Vis"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"6971","DOI":"10.1167\/iovs.15-17166","volume":"56","author":"A Dinculescu","year":"2015","unstructured":"Dinculescu A, Min S-H, Dyka FM et al (2015) Pathological effects of mutant C1QTNF5 (S163R) expression in murine retinal pigment epithelium. Invest Ophthalmol Vis Sci 56:6971\u20136980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0161-6420(00)00419-X","volume":"107","author":"AH Milam","year":"2000","unstructured":"Milam AH, Curcio CA, Cideciyan AV et al (2000) Dominant late-onset retinal degeneration with regional variation of sub-retinal pigment epithelium deposits, retinal function, and photoreceptor degeneration. Ophthalmology 107:2256\u20132266","journal-title":"Ophthalmology"},{"key":"1_CR105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1418840112","volume":"112","author":"A Milenkovic","year":"2015","unstructured":"Milenkovic A, Brandl C, Milenkovic VM et al (2015) Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells. Proc Natl Acad Sci U S A 112:E2630","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1085\/jgp.200509473","volume":"127","author":"LY Marmorstein","year":"2006","unstructured":"Marmorstein LY, Wu J, McLaughlin P et al (2006) The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by Bestrophin (Best-1). J Gen Physiol 127:577\u2013589","journal-title":"J Gen Physiol"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/81555","volume":"26","author":"A Gal","year":"2000","unstructured":"Gal A, Li Y, Thompson DA et al (2000) Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 26:270\u2013271","journal-title":"Nat Genet"},{"key":"1_CR108","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1083\/jcb.49.3.664","volume":"49","author":"D Bok","year":"1971","unstructured":"Bok D, Hall MO (1971) The role of the pigment epithelium in the etiology of inherited retinal dystrophy in the rat. J Cell Biol 49:664\u2013682","journal-title":"J Cell Biol"},{"key":"1_CR109","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1083\/jcb.14.1.73","volume":"14","author":"JE Dowling","year":"1962","unstructured":"Dowling JE, Sidman RL (1962) Inherited retinal dystrophy in the rat. J Cell Biol 14:73\u2013109","journal-title":"J Cell Biol"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-4835(75)90080-9","volume":"21","author":"MM LaVail","year":"1975","unstructured":"LaVail MM, Battelle BA (1975) Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res 21:167\u2013192","journal-title":"Exp Eye Res"},{"key":"1_CR111","first-page":"3149","volume":"41","author":"NL Hawes","year":"2000","unstructured":"Hawes NL, Chang B, Hageman GS et al (2000) Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens. Invest Ophthalmol Vis Sci 41:3149\u20133157","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR112","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/hmg\/11.16.1879","volume":"11","author":"S Kameya","year":"2002","unstructured":"Kameya S, Hawes NL, Chang B, Heckenlively JR, Naggert JK, Nishina PM (2002) Mfrp, a gene encoding a frizzled related protein, is mutated in the mouse retinal degeneration 6. Hum Mol Genet 11:1879\u20131886","journal-title":"Hum Mol Genet"},{"key":"1_CR113","doi-asserted-by":"publisher","first-page":"16151","DOI":"10.1038\/s41598-017-16275-8","volume":"7","author":"G Velez","year":"2017","unstructured":"Velez G, Tsang SH, Tsai YT et al (2017) Gene therapy restores Mfrp and corrects axial eye length. Sci Rep 7:16151","journal-title":"Sci Rep"},{"key":"1_CR114","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1167\/iovs.11-8112","volume":"52","author":"J Fogerty","year":"2011","unstructured":"Fogerty J, Besharse JC (2011) 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. Invest Ophthalmol Vis Sci 52:7256\u20137266","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR115","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1017\/S0952523808080723","volume":"25","author":"J Won","year":"2008","unstructured":"Won J, Smith RS, Peachey NS et al (2008) Membrane frizzled-related protein is necessary for the normal development and maintenance of photoreceptor outer segments. Vis Neurosci 25:563\u2013574","journal-title":"Vis Neurosci"},{"key":"1_CR116","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.mam.2012.06.003","volume":"33","author":"ME Pennesi","year":"2012","unstructured":"Pennesi ME, Neuringer M, Courtney RJ (2012) Animal models of age related macular degeneration. Mol Asp Med 33:487\u2013509","journal-title":"Mol Asp Med"},{"key":"1_CR117","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.freeradbiomed.2007.12.023","volume":"44","author":"AL Glotin","year":"2008","unstructured":"Glotin AL, Debacq-Chainiaux F, Brossas JY et al (2008) Prematurely senescent ARPE-19 cells display features of age-related macular degeneration. Free Radic Biol Med 44:1348\u20131361","journal-title":"Free Radic Biol Med"},{"key":"1_CR118","doi-asserted-by":"publisher","first-page":"18277","DOI":"10.1073\/pnas.1109703108","volume":"108","author":"LV Johnson","year":"2011","unstructured":"Johnson LV, Forest DL, Banna CD et al (2011) Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration. Proc Natl Acad Sci U S A 108:18277\u201318282","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR119","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1167\/iovs.16-21060","volume":"58","author":"MG Pilgrim","year":"2017","unstructured":"Pilgrim MG, Lengyel I, Lanzirotti A et al (2017) Subretinal pigment epithelial deposition of Drusen components including hydroxyapatite in a primary cell culture model. Invest Ophthalmol Vis Sci 58:708\u2013719","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR120","doi-asserted-by":"publisher","first-page":"9113","DOI":"10.1074\/jbc.M114.548669","volume":"289","author":"RA Radu","year":"2014","unstructured":"Radu RA, Hu J, Jiang Z, Bok D (2014) Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype. J Biol Chem 289:9113\u20139120","journal-title":"J Biol Chem"},{"key":"1_CR121","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"1_CR122","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1126\/science.1151526","volume":"318","author":"J Yu","year":"2007","unstructured":"Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318:1917\u20131920","journal-title":"Science"},{"key":"1_CR123","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00824","volume":"2","author":"BA Tucker","year":"2013","unstructured":"Tucker BA, Mullins RF, Streb LM et al (2013) Patient-specific iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. elife 2:e00824","journal-title":"elife"},{"key":"1_CR124","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.preteyeres.2014.10.002","volume":"44","author":"LA Wiley","year":"2015","unstructured":"Wiley LA, Burnight ER, Songstad AE et al (2015) Patient-specific induced pluripotent stem cells (iPSCs) for the study and treatment of retinal degenerative diseases. Prog Retin Eye Res 44:15\u201335","journal-title":"Prog Retin Eye Res"},{"key":"1_CR125","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/jcm3041511","volume":"3","author":"FK Chen","year":"2014","unstructured":"Chen FK, McLenachan S, Edel M, Da Cruz L, Coffey PJ, Mackey DA (2014) iPS cells for modelling and treatment of retinal diseases. J Clin Med 3:1511\u20131541","journal-title":"J Clin Med"},{"key":"1_CR126","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1167\/iovs.11-9313","volume":"53","author":"MJ Phillips","year":"2012","unstructured":"Phillips MJ, Wallace KA, Dickerson SJ et al (2012) Blood-derived human iPS cells generate optic vesicle-like structures with the capacity to form retinal laminae and develop synapses. Invest Ophthalmol Vis Sci 53:2007\u20132019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR127","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/stem.674","volume":"29","author":"JS Meyer","year":"2011","unstructured":"Meyer JS, Howden SE, Wallace KA et al (2011) Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment. Stem Cells 29:1206\u20131218","journal-title":"Stem Cells"},{"key":"1_CR128","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fnagi.2014.00191","volume":"6","author":"Y-C Chang","year":"2014","unstructured":"Chang Y-C, Chang W-C, Hung K-H et al (2014) The generation of induced pluripotent stem cells for macular degeneration as a drug screening platform: identification of curcumin as a protective agent for retinal pigment epithelial cells against oxidative stress. Front Aging Neurosci 6:191","journal-title":"Front Aging Neurosci"},{"key":"1_CR129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.5966\/sctm.2012-0040","volume":"2","author":"BA Tucker","year":"2013","unstructured":"Tucker BA, Anfinson KR, Mullins RF, Stone EM, Young MJ (2013) Use of a synthetic xeno-free culture substrate for induced pluripotent stem cell induction and retinal differentiation. Stem Cells Transl Med 2:16\u201324","journal-title":"Stem Cells Transl Med"},{"key":"1_CR130","doi-asserted-by":"publisher","first-page":"16698","DOI":"10.1073\/pnas.0905245106","volume":"106","author":"JS Meyer","year":"2009","unstructured":"Meyer JS, Shearer RL, Capowski EE et al (2009) Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A 106:16698\u201316703","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR131","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/stem.1667","volume":"32","author":"MJ Phillips","year":"2014","unstructured":"Phillips MJ, Perez ET, Martin JM et al (2014) Modeling human retinal development with patient-specific induced pluripotent stem cells reveals multiple roles for visual system homeobox 2. Stem Cells 32:1480\u20131492","journal-title":"Stem Cells"},{"issue":"R1","key":"1_CR132","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1093\/hmg\/ddu124","volume":"23","author":"BA Tucker","year":"2014","unstructured":"Tucker BA, Mullins RF, Stone EM (2014) Stem cells for investigation and treatment of inherited retinal disease. Hum Mol Genet 23(R1):R9\u2013R16","journal-title":"Hum Mol Genet"},{"issue":"9967","key":"1_CR133","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","volume":"385","author":"SD Schwartz","year":"2015","unstructured":"Schwartz SD, Regillo CD, Lam BL et al (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt\u2019s macular dystrophy: follow-up of two open-label phase 1\/2 studies. Lancet 385(9967):509\u2013516","journal-title":"Lancet"},{"key":"1_CR134","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1242\/dev.092270","volume":"140","author":"CM Ramsden","year":"2013","unstructured":"Ramsden CM, Powner MB, Carr AJ, Smart MJ, da Cruz L, Coffey PJ (2013) Stem cells in retinal regeneration: past, present and future. Development 140:2576\u20132585","journal-title":"Development"},{"key":"1_CR135","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/mt.2015.141","volume":"23","author":"R Singh","year":"2015","unstructured":"Singh R, Kuai D, Guziewicz KE et al (2015) Pharmacological modulation of photoreceptor outer segment degradation in a human iPS cell model of inherited macular degeneration. Mol Ther 23:1700\u20131711","journal-title":"Mol Ther"},{"key":"1_CR136","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/stem.2708","volume":"35","author":"D Hallam","year":"2017","unstructured":"Hallam D, Collin J, Bojic S et al (2017) An induced pluripotent stem cell patient specific model of complement factor H (Y402H) polymorphism displays characteristic features of age-related macular degeneration and indicates a beneficial role for UV light exposure. Stem Cells 35:2305\u20132320","journal-title":"Stem Cells"},{"key":"1_CR137","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.stem.2016.12.015","volume":"20","author":"JS Saini","year":"2017","unstructured":"Saini JS, Corneo B, Miller JD et al (2017) Nicotinamide ameliorates disease phenotypes in a human iPSC model of age-related macular degeneration. Cell Stem Cell 20:635\u2013647.e637","journal-title":"Cell Stem Cell"},{"key":"1_CR138","doi-asserted-by":"publisher","first-page":"503","DOI":"10.5966\/sctm.2012-0005","volume":"1","author":"ZB Jin","year":"2012","unstructured":"Jin ZB, Okamoto S, Xiang P, Takahashi M (2012) Integration-free induced pluripotent stem cells derived from retinitis pigmentosa patient for disease modeling. Stem Cells Transl Med 1:503\u2013509","journal-title":"Stem Cells Transl Med"},{"key":"1_CR139","first-page":"1236","volume":"37","author":"CA Curcio","year":"1996","unstructured":"Curcio CA, Medeiros NE, Millican CL (1996) Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci 37:1236\u20131249","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR140","first-page":"1691","volume":"30","author":"CK Dorey","year":"1989","unstructured":"Dorey CK, Wu G, Ebenstein D, Garsd A, Weiter JJ (1989) Cell loss in the aging retina. Relationship to lipofuscin accumulation and macular degeneration. Invest Ophthalmol Vis Sci 30:1691\u20131699","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR141","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/00006982-199414040-00006","volume":"14","author":"FG Holz","year":"1994","unstructured":"Holz FG, Haimovici R, Wagner DG, Bird AC (1994) Recurrent choroidal neovascularization after laser photocoagulation in Sorsby\u2019s fundus dystrophy. Retina 14:329\u2013334","journal-title":"Retina"},{"key":"1_CR142","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1167\/iovs.05-1600","volume":"47","author":"M Michaelides","year":"2006","unstructured":"Michaelides M, Jenkins SA, Brantley JMA et al (2006) Maculopathy due to the R345W substitution in fibulin-3: distinct clinical features, disease variability, and extent of retinal dysfunction. Invest Ophthalmol Vis Sci 47:3085\u20133097","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR143","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1600-0420.2007.00927.x","volume":"85","author":"F Prager","year":"2007","unstructured":"Prager F, Michels S, Geitzenauer W, Schmidt-Erfurth U (2007) Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin). Acta Ophthalmol Scand 85:904\u2013906","journal-title":"Acta Ophthalmol Scand"},{"key":"1_CR144","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bios.2015.04.079","volume":"71","author":"W Gamal","year":"2015","unstructured":"Gamal W, Borooah S, Smith S et al (2015) Real-time quantitative monitoring of hiPSC-based model of macular degeneration on electric cell-substrate impedance sensing microelectrodes. Biosens Bioelectron 71:445\u2013455","journal-title":"Biosens Bioelectron"},{"key":"1_CR145","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1073\/pnas.81.12.3761","volume":"81","author":"I Giaever","year":"1984","unstructured":"Giaever I, Keese CR (1984) Monitoring fibroblast behavior in tissue-culture with an applied electric-field. Proc Natl Acad Sci U S A 81:3761\u20133764","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR146","doi-asserted-by":"publisher","first-page":"7896","DOI":"10.1073\/pnas.88.17.7896","volume":"88","author":"I Giaever","year":"1991","unstructured":"Giaever I, Keese CR (1991) Micromotion of mammalian-cells measured electrically. Proc Natl Acad Sci U S A 88:7896\u20137900","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR147","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cell.2006.05.029","volume":"125","author":"SL Gupton","year":"2006","unstructured":"Gupton SL, Waterman-Storer CM (2006) Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell 125:1361\u20131374","journal-title":"Cell"},{"key":"1_CR148","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1093\/hmg\/ddu053","volume":"23","author":"J Yang","year":"2014","unstructured":"Yang J, Li Y, Chan L et al (2014) Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines. Hum Mol Genet 23:3445\u20133455","journal-title":"Hum Mol Genet"},{"key":"1_CR149","doi-asserted-by":"publisher","unstructured":"Golestaneh N, Chu Y, Cheng SK, Cao H, Poliakov E, Berinstein DM (2016) Repressed SIRT1\/PGC-1\u03b1 pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J Transl Med. 14(1):344. Published 2016 Dec 20. \n                  https:\/\/doi.org\/10.1186\/s12967-016-1101-8","DOI":"10.1186\/s12967-016-1101-8"},{"key":"1_CR150","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.ophtha.2017.12.023","volume":"125","author":"L Lores-Motta","year":"2018","unstructured":"Lores-Motta L, Paun CC, Corominas J et al (2018) Genome-wide association study reveals variants in CFH and CFHR4 associated with systemic complement activation: implications in age-related macular degeneration. Ophthalmology 125:1064","journal-title":"Ophthalmology"},{"key":"1_CR151","doi-asserted-by":"publisher","first-page":"7480","DOI":"10.1167\/iovs.15-17251","volume":"56","author":"TY Garcia","year":"2015","unstructured":"Garcia TY, Gutierrez M, Reynolds J, Lamba DA (2015) Modeling the dynamic AMD-associated chronic oxidative stress changes in human ESC and iPSC-derived RPE cells. Invest Ophthalmol Vis Sci 56:7480\u20137488","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR152","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1152\/advan.00052.2006","volume":"30","author":"H Liang","year":"2006","unstructured":"Liang H, Ward WF (2006) PGC-1alpha: a key regulator of energy metabolism. Adv Physiol Educ 30:145\u2013151","journal-title":"Adv Physiol Educ"},{"key":"1_CR153","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","volume":"20","author":"C Canto","year":"2009","unstructured":"Canto C, Auwerx J (2009) PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol 20:98\u2013105","journal-title":"Curr Opin Lipidol"},{"key":"1_CR154","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/stem.2783","volume":"36","author":"A Artero Castro","year":"2018","unstructured":"Artero Castro A, Lukovic D, Jendelova P, Erceg S (2018) Concise review: human induced pluripotent stem cell models of retinitis pigmentosa. Stem Cells 36:474\u2013481","journal-title":"Stem Cells"},{"key":"1_CR155","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1167\/iovs.08-2742","volume":"51","author":"S Brunner","year":"2010","unstructured":"Brunner S, Skosyrski S, Kirschner-Schwabe R et al (2010) Cone versus rod disease in a mutant Rpgr mouse caused by different genetic backgrounds. Invest Ophthalmol Vis Sci 51:1106\u20131115","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR156","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/path.4641","volume":"238","author":"C Kostic","year":"2016","unstructured":"Kostic C, Arsenijevic Y (2016) Animal modelling for inherited central vision loss. J Pathol 238:300\u2013310","journal-title":"J Pathol"},{"key":"1_CR157","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/eye.2016.197","volume":"30","author":"FS Sorrentino","year":"2016","unstructured":"Sorrentino FS, Gallenga CE, Bonifazzi C, Perri P (2016) A challenge to the striking genotypic heterogeneity of retinitis pigmentosa: a better understanding of the pathophysiology using the newest genetic strategies. Eye 30:1542","journal-title":"Eye"},{"key":"1_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017084","volume":"6","author":"Z-B Jin","year":"2011","unstructured":"Jin Z-B, Okamoto S, Osakada F et al (2011) Modeling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS One 6:e17084","journal-title":"PLoS One"},{"key":"1_CR159","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1756-6606-7-45","volume":"7","author":"T Yoshida","year":"2014","unstructured":"Yoshida T, Ozawa Y, Suzuki K et al (2014) The use of induced pluripotent stem cells to reveal pathogenic gene mutations and explore treatments for retinitis pigmentosa. Mol Brain 7:45","journal-title":"Mol Brain"},{"key":"1_CR160","doi-asserted-by":"publisher","first-page":"E569","DOI":"10.1073\/pnas.1108918108","volume":"108","author":"BA Tucker","year":"2011","unstructured":"Tucker BA, Scheetz TE, Mullins RF et al (2011) Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc Natl Acad Sci U S A 108:E569\u2013E576","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR161","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/hmg\/ddu509","volume":"24","author":"N Schwarz","year":"2015","unstructured":"Schwarz N, Carr AJ, Lane A et al (2015) Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet 24:972\u2013986","journal-title":"Hum Mol Genet"},{"key":"1_CR162","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.trsl.2015.08.007","volume":"166","author":"BA Tucker","year":"2015","unstructured":"Tucker BA, Cranston CM, Anfinson KA et al (2015) Using patient-specific induced pluripotent stem cells to interrogate the pathogenicity of a novel retinal pigment epithelium-specific 65 kDa cryptic splice site mutation and confirm eligibility for enrollment into a clinical gene augmentation trial. Transl Res 166:740\u2013749.e741","journal-title":"Transl Res"},{"key":"1_CR163","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1073\/pnas.220402097","volume":"97","author":"AD Marmorstein","year":"2000","unstructured":"Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K (2000) Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A 97:12758\u201312763","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR164","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3109\/13816810.2013.863945","volume":"36","author":"C Pasquay","year":"2015","unstructured":"Pasquay C, Wang LF, Lorenz B, Preising MN (2015) Bestrophin 1\u2014phenotypes and functional aspects in Bestrophinopathies. Ophthalmic Genet 36:193\u2013212","journal-title":"Ophthalmic Genet"},{"key":"1_CR165","doi-asserted-by":"publisher","first-page":"112","DOI":"10.12998\/wjcc.v3.i2.112","volume":"3","author":"OF Chacon-Camacho","year":"2015","unstructured":"Chacon-Camacho OF, Zenteno JC (2015) Review and update on the molecular basis of Leber congenital amaurosis. World J Clin Cases 3:112\u2013124","journal-title":"World J Clin Cases"},{"key":"1_CR166","doi-asserted-by":"publisher","first-page":"12320","DOI":"10.1038\/s41598-017-12396-2","volume":"7","author":"V Chichagova","year":"2017","unstructured":"Chichagova V, Hallam D, Collin J et al (2017) Human iPSC disease modelling reveals functional and structural defects in retinal pigment epithelial cells harbouring the m.3243A > G mitochondrial DNA mutation. Sci Rep 7:12320","journal-title":"Sci Rep"},{"key":"1_CR167","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S1091-8531(97)90010-0","volume":"1","author":"PH Phillips","year":"1997","unstructured":"Phillips PH, Newman NJ (1997) Mitochondrial diseases in pediatric ophthalmology. J AAPOS 1:115\u2013122","journal-title":"J AAPOS"},{"key":"1_CR168","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/archopht.126.3.320","volume":"126","author":"M Michaelides","year":"2008","unstructured":"Michaelides M, Jenkins SA, Bamiou DE et al (2008) Macular dystrophy associated with the A3243G mitochondrial DNA mutation. Distinct retinal and associated features, disease variability, and characterization of asymptomatic family members. Arch Ophthalmol 126:320\u2013328","journal-title":"Arch Ophthalmol"},{"key":"1_CR169","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.sjopt.2011.02.002","volume":"25","author":"GS Gorman","year":"2011","unstructured":"Gorman GS, Taylor RW (2011) Mitochondrial DNA abnormalities in ophthalmological disease. Saudi J Ophthalmol 25:395\u2013404","journal-title":"Saudi J Ophthalmol"},{"key":"1_CR170","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0161-6420(13)31404-3","volume":"100","author":"V Rummelt","year":"1993","unstructured":"Rummelt V, Folberg R, Ionasescu V, Yi H, Moore KC (1993) Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology 100:1757\u20131766","journal-title":"Ophthalmology"},{"key":"1_CR171","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/archopht.1993.01090090106028","volume":"111","author":"TS Chang","year":"1993","unstructured":"Chang TS, Johns DR, Walker D, de la Cruz Z, Maumence IH, Green WR (1993) Ocular clinicopathologic study of the mitochondrial encephalomyopathy overlap syndromes. Arch Ophthalmol 111:1254\u20131262","journal-title":"Arch Ophthalmol"},{"key":"1_CR173","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12967-016-1101-8","volume":"14","author":"N Golestaneh","year":"2016","unstructured":"Golestaneh N, Chu Y, Cheng SK, Cao H, Poliakov E, Berinstein DM (2016) Repressed SIRT1\/PGC-1alpha pathway and mitochondrial disintegration in iPSC-derived RPE disease model of age-related macular degeneration. J Transl Med 14:344","journal-title":"J Transl Med"},{"key":"1_CR174","doi-asserted-by":"publisher","first-page":"6767","DOI":"10.1167\/iovs.13-11943","volume":"54","author":"R Singh","year":"2013","unstructured":"Singh R, Phillips MJ, Kuai D et al (2013) Functional analysis of serially expanded human iPS cell-derived RPE cultures. Invest Ophthalmol Vis Sci 54:6767\u20136778","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1_CR175","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.stemcr.2018.05.012","volume":"10","author":"WL Deng","year":"2018","unstructured":"Deng WL, Gao ML, Lei XL et al (2018) Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients. Stem Cell Rep 10:2005","journal-title":"Stem Cell Rep"},{"key":"1_CR176","doi-asserted-by":"publisher","first-page":"29784","DOI":"10.1038\/srep29784","volume":"6","author":"AO Barnea-Cramer","year":"2016","unstructured":"Barnea-Cramer AO, Wang W, Lu SJ et al (2016) Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice. Sci Rep 6:29784","journal-title":"Sci Rep"},{"key":"1_CR177","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41598-017-00774-9","volume":"7","author":"KJ Wahlin","year":"2017","unstructured":"Wahlin KJ, Maruotti JA, Sripathi SR et al (2017) Photoreceptor outer segment-like structures in long-term 3D retinas from human pluripotent stem cells. Sci Rep 7:766","journal-title":"Sci Rep"},{"key":"1_CR178","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2012.01.003","volume":"148","author":"TA Rando","year":"2012","unstructured":"Rando TA, Chang HY (2012) Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148:46\u201357","journal-title":"Cell"},{"key":"1_CR179","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.scr.2018.01.014","volume":"27","author":"VM Parmar","year":"2018","unstructured":"Parmar VM, Parmar T, Arai E, Perusek L, Maeda A (2018) A2E-associated cell death and inflammation in retinal pigmented epithelial cells from human induced pluripotent stem cells. Stem Cell Res 27:95\u2013104","journal-title":"Stem Cell Res"},{"key":"1_CR180","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-1-59745-186-4_13","volume-title":"Retinal degenerations: biology, diagnostics, and therapeutics","author":"MM Edwards","year":"2007","unstructured":"Edwards MM, Maddox DM, Won J, Naggert JK, Nishina PM (2007) Genetic modifiers that affect phenotypic expression of retinal diseases. In: Tombran-Tink J, Barnstable CJ (eds) Retinal degenerations: biology, diagnostics, and therapeutics. Humana, Totowa, NJ, pp 237\u2013255"},{"key":"1_CR181","doi-asserted-by":"publisher","first-page":"641","DOI":"10.5966\/sctm.2012-0043","volume":"1","author":"AM Vitale","year":"2012","unstructured":"Vitale AM, Matigian NA, Ravishankar S et al (2012) Variability in the generation of induced pluripotent stem cells: importance for disease modeling. Stem Cells Transl Med 1:641\u2013650","journal-title":"Stem Cells Transl Med"},{"key":"1_CR182","first-page":"39","volume":"2","author":"D Steinemann","year":"2013","unstructured":"Steinemann D, Gohring G, Schlegelberger B (2013) Genetic instability of modified stem cells - a first step towards malignant transformation? Am J Stem Cells 2:39\u201351","journal-title":"Am J Stem Cells"},{"key":"1_CR183","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.stem.2009.11.009","volume":"5","author":"K Saha","year":"2009","unstructured":"Saha K, Jaenisch R (2009) Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell 5:584\u2013595","journal-title":"Cell Stem Cell"},{"key":"1_CR184","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/jcm4040567","volume":"4","author":"HV Nguyen","year":"2015","unstructured":"Nguyen HV, Li Y, Tsang SH (2015) Patient-specific iPSC-derived RPE for modeling of retinal diseases. J Clin Med 4:567\u2013578","journal-title":"J Clin Med"},{"key":"1_CR185","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.stem.2017.06.012","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem MS, Osipovitch M, Liu Z et al (2017) Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell 21:195\u2013208.e196","journal-title":"Cell Stem Cell"},{"key":"1_CR186","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/clo.2006.8.189","volume":"8","author":"RD Lund","year":"2006","unstructured":"Lund RD, Wang S, Klimanskaya I et al (2006) Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats. Cloning Stem Cells 8:189\u2013199","journal-title":"Cloning Stem Cells"},{"key":"1_CR187","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/glia.22862","volume":"63","author":"SA Goldman","year":"2015","unstructured":"Goldman SA, Nedergaard M, Windrem MS (2015) Modeling cognition and disease using human glial chimeric mice. Glia 63:1483\u20131493","journal-title":"Glia"}],"container-title":["Advances in Experimental Medicine and Biology","Pluripotent Stem Cells in Eye Disease Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-28471-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T22:04:12Z","timestamp":1572041052000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-28471-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030284701","9783030284718"],"references-count":186,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-28471-8_1","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"26 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}